Quock R M, Kouchich F J, Vaughn L K, Fries D S
Life Sci. 1985 Sep 2;37(9):819-26. doi: 10.1016/0024-3205(85)90516-8.
Intravenous naloxone or naltrexone produced transient, dose-related reductions in the mean arterial pressure (MAP) and heart rate (HR) of urethane-anesthetized spontaneously hypertensive rats (SHRs). Yet these same doses of narcotic antagonists reduced HR but not MAP of normotensive Wistar-Kyoto rats (WKYs). Such effects were not observed upon administration to SHRs of increasing doses of methylnaltrexone, which possesses no central activity. (+)-Naloxone, which does not block opiate receptors, reduced HR but not MAP of both SHRs and WKYs. These findings indicate that SHRs and WKYs differ in their MAP and HR responses to narcotic antagonists. The high doses required for effect plus the brevity of the responses suggest that these drug effects are perhaps not mu-opiate receptor-mediated; however, the methylnaltrexone and (+)-naloxone findings clearly implicate a central specificity of action. We conclude that narcotic antagonist-induced changes in MAP and HR in SHRs are possibly specific and central in origin yet not mediated by mu-opiate receptors.
静脉注射纳洛酮或纳曲酮可使氨基甲酸乙酯麻醉的自发性高血压大鼠(SHR)的平均动脉压(MAP)和心率(HR)出现短暂的、与剂量相关的降低。然而,相同剂量的麻醉拮抗剂可降低正常血压的Wistar-Kyoto大鼠(WKY)的心率,但不影响其平均动脉压。对SHR给予递增剂量的无中枢活性的甲基纳曲酮后未观察到此类效应。不阻断阿片受体的(+)-纳洛酮可降低SHR和WKY的心率,但不影响其平均动脉压。这些发现表明,SHR和WKY对麻醉拮抗剂的MAP和HR反应不同。产生效应所需的高剂量以及反应的短暂性表明,这些药物效应可能不是由μ-阿片受体介导的;然而,甲基纳曲酮和(+)-纳洛酮的研究结果明确表明存在作用的中枢特异性。我们得出结论,麻醉拮抗剂引起的SHR的MAP和HR变化可能起源于特定的中枢,但并非由μ-阿片受体介导。